Medical Treatment Related Content
Turning the national illness service into the national health service
Robin Stern, Chair at Future Perfect (Healthcare), discusses how patient journeys currently reflect a national 'illness' service, not a national health service.
Only 16% of men received HPV vaccine
Researchers from Michigan Medicine have found that only 16% of men had received at least one dose of the HPV vaccine.
COVID oxygen use increases risk of hospital fires
In India and Iraq, patients recently died in hospital fires caused by oxygen explosions - an increased amount of oxygen is needed to treat COVID-19.
Foot test can detect heart rhythm disorder in diabetic patients
A simple annual foot test can help detect atrial fibrillation in patients with diabetes, according to research presented at EHRA 2021.
Scientists work on blood test to diagnose heart attacks
Scientists are creating a blood test that can quickly diagnose heart attacks - by looking for the "unique fingerprint" of a heart attack.
Life expectancy is up for HIV patients in Latin America
Researchers studied over 30,688 HIV patients across seven Latin American countries - finding that life expectancy has dramatically increased over a period of 14 years.
Trial finds York/Hull leishmaniasis vaccine is safe
A new vaccine, developed by researchers at the Hull York Medical School, to treat leishmaniasis has proved to be safe in the first clinical trials.
Asthma drug shortens COVID-19 recovery time
Budesonide, a drug used to treat asthma, has been found to shorten recovery time in COVID-19 patients who are treated at home.
CBD oil for ADHD: What the research shows
CBD oil is popular for its wide-ranging therapeutic benefits, but what about its effects on ADHD? Here’s what the research shows.
Cannabis as a treatment for COVID-19
Kevin William Simpson, CEO and Founder of OilsBySimpson, tells us about the growing evidence around cannabis as a treatment for COVID-19.
Improving cancer treatment and services during and beyond COVID-19
Greg Quinn, BD UK, explores how cancer treatment and services have been impacted by the pandemic and the potential role of medical technology in supporting the NHS during this complex time.
Biosimilars: Improve access to treatment & reduce cost
Tore K Kvien & Guro L Goll argue that biosimilars are an opportunity for improving access to treatment & reducing cost and provide comment on the NOR-SWITCH study.
Data finds 36% of people refuse COVID vaccine due to side effect fears
According to new ONS data, 36% of UK people who are vaccine hesitant have strong side effect fears - while a further 12% fear needles, and 22% think vaccines could impact fertility.
Driving the epilepsy field ahead with new research benchmarks
The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), drives the epilepsy field ahead with new research benchmarks, Vicky Whittemore, PhD, Program Director reveals.
A simple prescription for healing chronic disease
Dr Shireen Kassam MBBS, FRCPath, PhD, dipIBLM, Founder and Director of Plant-Based Health Professionals UK, explains a simple prescription for health as a remedy to chronic disease.
From insulin to immunotherapy: A century of discovery
Dr Faye Riley, Senior Research Communications Officer at Diabetes UK, highlights how immunotherapy is raising hopes for the next big breakthrough in type 1 diabetes.
FLASH Radiotherapy: An (r)evolution in cancer treatment
Here, Kristoffer Petersson, MRC Investigator and Group Leader of FLASH Radiation, enlightens us to the benefits of this promising new radiotherapy technique.
The changing perspective of psychedelic drugs with a history of abuse
Jason W. Loxterkamp and Pamela J. Lein from University of California, Davis, explore the therapeutic potential of psychedelic drugs in patients with psychiatric disorders.
Understanding personality disorders
Dr Deborah J Lee, Dr Fox Online Pharmacy, tells us everything we need to know about personality disorders, including how they are diagnosed and treated.
European Medicines Agency say AstraZeneca does not cause blood clots
The safety committee of the European Medicines Agency said the investigation did not prove that AstraZeneca vaccinations cause blood clots - describing the possibility as an "extremely small likelihood".